Answers are grounded in this paper and cite their sources.
Ethics review is an “intervention” in the system of health care that has been less evaluated than others. It aims to minimise risks to patients from inappropriate research or inadequate consent, but as a consequence it may delay or inhibit research beneficial to those same patients. The balance of risks and consequences will clearly be different for different types of research: some questionnaires, clinical audits, or comparisons of standard treatments are associated with low risks, while comparisons of known treatments against placebo and studies of new, potentially dangerous interventions carry higher risks.
No takes yet. Share an insight, caveat, or question.
Paul Glasziou (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: